315
Participants
Start Date
January 31, 2026
Primary Completion Date
June 30, 2026
Study Completion Date
September 30, 2026
emodepside (BAY 44-4400)
Treatment with single dose of oral 15 mg emodepside
Mebendazole 100 MG
Treatment with 100 mg mebendazole orally administered b.i.d. for 3 days
similar placebo to mebendazole
Treatment with mebendazole similar placebo orally administered b.i.d. for 3 days
matching placebo of emodepside
Treatment with single dose of oral emodepside matching placebo
University of the Philippines Manila, Manila
Collaborators (1)
Bayer
INDUSTRY
Silicon Valley Community Foundation
OTHER
University of the Philippines
OTHER
Swiss Tropical & Public Health Institute
OTHER